Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education



Front Page

World

UK

UK Politics

Business

Sci/Tech

Health

Education

Sport

Entertainment

Talking Point
On Air
Feedback
Low Graphics
Help

Sunday, November 15, 1998 Published at 10:33 GMT


Health

Pharmacist's painkiller warning



A popular over-the-counter painkiller could cause a "potentially huge abuse problem", a pharmacist has warned.

Nurofen Plus is made up of ibuprofen and codeine, the latter an opium derivative which is used by some addicts to get high.

On its own, codeine is only available on prescription in the UK but it can be obtained in compound form, such as in Nurofen Plus and cough medicines.

As well as being used by drug abusers, codeine is also used by some heroin addicts to ward off withdrawal symptoms if they cannot get hold of the drug.

Writing in the Pharmaceutical Journal, chemist Bharat Nathwani, warned: "In the world of drug addicts, this product must be a Godsend.

"There are over 12mg of codeine in every tablet. A pack of 24 tablets contains more codeine than a 100ml bottle of codeine linctus.

"The codeine part is easily separable and in central London addicts seem to know about this already."

Mr Nathwani, of Pinner, Middlesex, has warned pharmacists to be alert to the possibility that customers might be abusing the tablets.

However, manufacturers Crookes Healthcare played down the dangers.

A spokeswoman said only two cases of codeine-abuse linked to the drug had been reported since it was launched, compared with sales of nearly 200 million tablets.

She said the dual action of the codeine and ibruprofen were what made the drug so effective and fast-acting.

"It has been subject to stringent tests and classified as a safe drug to be sold over the counter.

"Tests have shown that its addictive potential is very low and it would need to be taken in very large amounts to achieve a euphoric state."

Crookes added that any comments about their drugs were taken on board and included in future product development.



Advanced options | Search tips




Back to top | BBC News Home | BBC Homepage |


Health Contents

Background Briefings
Medical notes
Internet Links


The Royal Pharmaceutical Society of Great Britain

Details about Nurofen


The BBC is not responsible for the content of external internet sites.




In this section

Disability in depth

Spotlight: Bristol inquiry

Antibiotics: A fading wonder

Mental health: An overview

Alternative medicine: A growth industry

The meningitis files

Long-term care: A special report

Aids up close

From cradle to grave

NHS reforms: A guide

NHS Performance 1999

From Special Report
NHS in crisis: Special report

British Medical Association conference '99

Royal College of Nursing conference '99